Evidence map›Paper›PMID 34982011›Full record

ArticleTechnology in cancer research & treatment

PHLPP1 Overexpression was Associated With a Good Prognosis With Decreased AKT Activity in Gastric Cancer.

Sun Yi Park, Sang-Ho Jeong, Eun-Jung Jung, Young-Tae Ju, Chi-Young Jeong, Ju-Yeon Kim, Taejin Park, Jiho Park, Tae-Han Kim, Miyeong Park and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Sun Yi Park26720Gyeongsang National University, Jinju, South Korea.
Sang-Ho Jeong26720Gyeongsang National University, Jinju, South Korea.ORCID 0000-0001-9061-6236
Eun-Jung Jung26720Gyeongsang National University, Jinju, South Korea.
Young-Tae Ju26720Gyeongsang National University, Jinju, South Korea.
Chi-Young Jeong26720Gyeongsang National University, Jinju, South Korea.
Ju-Yeon Kim26720Gyeongsang National University, Jinju, South Korea.
Taejin Park553954Gyeongsang National University Changwon Hospital, Changwon, South Korea.
Jiho Park26720Gyeongsang National University, Jinju, South Korea.
Tae-Han Kim553954Gyeongsang National University Changwon Hospital, Changwon, South Korea.
Miyeong Park553954Gyeongsang National University Changwon Hospital, Changwon, South Korea.
Jung Wook YangGyeongsang National University Hospital, Jinju, South Korea.
Young-Joon Lee26720Gyeongsang National University, Jinju, South Korea.
Changwon National University · KRGyeongsang National University · KRGyeongsang National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorGene ExpressionAntineoplastic AgentsCell Line, TumorEnzyme ActivationGene Expression Regulation, NeoplasticHumansImmunohistochemistryNeoplasm GradingNeoplasm StagingNuclear ProteinsPhosphoprotein PhosphatasesPrognosisProto-Oncogene Proteins c-aktStomach NeoplasmsAntineoplastic AgentsBiomarkers, TumorNuclear ProteinsPHLPP1 protein, humanPhosphoprotein PhosphatasesProto-Oncogene Proteins c-aktbiomarkerimmunohistochemistryNGSprognosisstomach neoplasm

Identifiers

PMID34982011
PMCPMC8733352
OpenAlexW4206052005

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.